Thus, it is not surprising that both COX-1 and COX-2 have been included in a panel of inflammatory markers that characterize the rapidly growing and highly aggressive (type II) ovarian carcinomas [112]. This evidence concerns the gene PTGS2 and ovarian carcinoma.